Evidence map›Paper›PMID 40925305›Full record

ArticleInternational journal of surgery case reports2025

Primary diffuse large B-cell lymphoma of non-germinal center type with BCL-6 positivity in the kidney: A case report.

Yang-Wenyi Liu, Yan He, Yu Zhang, Ye-Ping Zhang, Jing Chen, Chao-Hua Deng

Abstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yang-Wenyi LiuDepartment of Urology, The Fourth Affiliated Hospital of Dali University, Chuxiong, Yunnan 675000, China.
Yan HeDepartment of Urology, The Fourth Affiliated Hospital of Dali University, Chuxiong, Yunnan 675000, China.
Yu ZhangDepartment of Urology, The Fourth Affiliated Hospital of Dali University, Chuxiong, Yunnan 675000, China.
Ye-Ping ZhangDepartment of Pathology, The Fourth Affiliated Hospital of Dali University, Chuxiong 675000, Yunnan Province, China.
Jing ChenDepartment of Nuclear Magnetic Resonance, The Fourth Affiliated Hospital of Dali University, Chuxiong 675000, Yunnan Province, China.
Chao-Hua DengDepartment of Urology, The Fourth Affiliated Hospital of Dali University, Chuxiong, Yunnan 675000, China. Electronic address: 2638522518@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and importanceDiffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma, yet primary renal involvement is rare, constituting less than 1 % of renal malignancies. A case of non-germinal center B-cell-like (non-GCB) DLBCL with BCL-6 positivity is particularly unique. Conventionally, BCL-6 is linked to germinal center B-cell-like (GCB) subtypes. This case defies traditional phenotypic classifications, highlighting the diagnostic and therapeutic complexities in treating rare renal lymphomas. Understanding such cases is crucial for improving patient care and advancing lymphoma research. CASE PRESENTATION: A 71-year-old male with left low back pain and hematuria had a 6.4 × 3.2 cm renal mass. Laparoscopic nephrectomy revealed CD20+/PAX-5+/CD38+ DLBCL, classified as non-GCB by the Hans algorithm. Initially stage I, lymphadenopathies and bone lesions post - op led to 5 cycles of R-CHOP, achieving 8-month complete remission. CLINICAL DISCUSSION: This first-reported case questions the Hans algorithm's BCL-6-based GCB classification. Pre-op misdiagnosis as renal cell carcinoma stresses pathological confirmation. Lack of PET-CT and molecular profiling limits tumor understanding. R-CHOP's success may relate to BCL-6-mediated chemosensitivity in non-GCB DLBCL.

conclusionThis rare case emphasizes comprehensive pathological subtyping, PET-CT staging, and molecular profiling. Standardized protocols and long-term follow-up are vital for managing such uncommon lymphoma subtypes.

Indexed as

BCL-6Diffuse large B-cell lymphomaNon-GCB subtypeRenal lymphoma

Identifiers

PMID40925305
PMCPMC12454620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.